Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
AIM ImmunoTech Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $24.32M | $20.68M - $27.95M | -$24.32M | $0.10 | 1 |
| Dec 2029 | $74.5K | $63.3K - $85.6K | -$74.5K | -$0.60 | 1 |
| Dec 2028 | $51.04M | $43.42M - $58.67M | -$51.04M | -$0.73 | 1 |
| Dec 2027 | $100.0K | $85.1K - $114.9K | -$100.0K | -$0.705 | 1 |
| Dec 2026 | $61.0K | $51.9K - $70.1K | -$61.0K | -$0.90 | 1 |
| Dec 2025 | $100.0K | $85.1K - $114.9K | -$100.0K | -$7.742 | 1 |
| Dec 2024 | $200.0K | $170.1K - $229.9K | -$200.0K | -$29.97 | 1 |
| Dec 2023 | $201.0K | $171.0K - $231.0K | -$201.0K | -$0.561 | 1 |
| Dec 2022 | $239.7K | $239.7K - $239.7K | -$239.7K | -$42.333 | 1 |
| Dec 2021 | $120.7K | $120.7K - $120.7K | -$120.7K | -$36.333 | 1 |
| Dec 2020 | $167.7K | $167.7K - $167.7K | -$167.7K | -$42.667 | 1 |
| Dec 2019 | $240.7K | $240.7K - $240.7K | -$240.7K | -$297.333 | 1 |